The availability of IHC techniques for detecting CSF1R protein and other members of the CSF1R/CSF pathway in tissues represent potential valuable approaches to identify future biomarkers and also therapeutic targets for high risk cHL. The gene discussed is CSF1R; the disease is classic Hodgkin lymphoma.